IE 11 is not supported. For an optimal experience visit our site on another browser.

FDA appears to be slow-walking vaccine approvals

The FDA said it was requiring a new clinical trial for the Novavax Covid vaccine. Experts see a playbook for delaying other immunizations.

FDA appears to be slow-walking vaccine approvals

The FDA said it was requiring a new clinical trial for the Novavax Covid vaccine. Experts see a playbook for delaying other immunizations.


What experts are saying on why Shedeur Sanders fell to the NFL draft's fifth round

There were questions about the QB's arm strength and ability to throw quickly. But that doesn't fully explain why he fell so far.

What experts are saying on why Shedeur Sanders fell to the NFL draft's fifth round

There were questions about the QB's arm strength and ability to throw quickly. But that doesn't fully explain why he fell so far.

LIVE

Power slowly returns in Spain as officials investigate cause of outage

The massive blackout disrupted travel and plunged shops and offices into darkness for more than nine hours.
LIVE

Power slowly returns in Spain as officials investigate cause of outage

The massive blackout disrupted travel and plunged shops and offices into darkness for more than nine hours.
Complete recovery from outage could take days, officials say

What we know about the deadly car ramming at a Vancouver street festival

Eleven people were killed and more than two dozen others were injured in the Saturday night attack.
Mourners attend a candlelight vigil near the scene where a car drove into a crowd of people during the Lapu Lapu Festival on April 27, 2025 in Vancouver, Canada.
Police do not believe the Vancouver attack was an act of terrorism
Live / 

Top Story With Tom Llamas


LATEST NEWS

Harvard has become a symbol of resistance for defying Trump. But on campus, students and faculty fear they're under attack.
There are 16 surviving members of this family in Gaza, enduring a life that has come to feel like death.
Tim Walz.
Democrats are increasingly acknowledging that society needs to fundamentally change post-Trump. They just can't agree on how.


For some cancer patients, immunotherapy may be a way to skip surgery and chemo

Research suggests that immunotherapy could be used as a first-line treatment for early-stage mismatch repair deficient cancers.

For some cancer patients, immunotherapy may be a way to skip surgery and chemo

Research suggests that immunotherapy could be used as a first-line treatment for early-stage mismatch repair deficient cancers.
Maureen Sideris
How an experimental treatment could help some cancer patients avoid surgery

Local

Your personalized news, including saved and local stories

Access these features with your free account.

user-unauthenticated icon

Your Local News

* Not a valid ZIP Code